STEPHANIE WOOSLEY: Open Payments
NPI 1760973895 · BRANDENBURG, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$202 in 12 payments from 7 companies in 2025. Trend: 2023 $46 · 2024 $0 · 2025 $202
Food & beverage: $202
| Company | Payments | Amount |
|---|---|---|
| Corcept Therapeutics | 4 | $76 |
| Novo Nordisk Inc | 2 | $32 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $30 |
| Phathom Pharmaceuticals, Inc. | 1 | $21 |
| Otsuka America Pharmaceutical, Inc. | 1 | $16 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $15 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $14 |
Products named: Korlym, Kerendia, VOQUEZNA, Rybelsus, REXULTI, CAPLYTA, Wegovy, JARDIANCE.
Industry payments across KY — which companies pay providers there.
